Bright Minds Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 25

Employees

  • Stock Symbol
  • DRUG

Stock Symbol

  • Share Price
  • $22.96
  • (As of Friday Closing)

Bright Minds General Information

Description

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Contact Information

Formerly Known As
1210954 B.C.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 19 Vestry Street
  • New York, NY 10013
  • United States
+1 (647)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
CNQ
Vertical(s)
Corporate Office
  • 19 Vestry Street
  • New York, NY 10013
  • United States
+1 (647)

Bright Minds Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bright Minds Stock Performance

As of 13-Nov-2026, Bright Minds’s stock price is $22.96. Its current market cap is $226M with 9.9M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$22.96 $23.15 $18.53 - $123.42 $226M 9.9M 1.01K -$2.05

Bright Minds Financials Summary

As of 30-Jun-2026, Bright Minds has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 30-Sep-2025 FY 2024 30-Sep-2024 FY 2023 30-Sep-2023
EV 486,378 393,004 285 52
Revenue 0 0 0 0
EBITDA (22,618) (9,761) (2,027) (5,407)
Net Income (17,731) (8,731) (2,059) (5,461)
Total Assets 218,368 60,659 4,518 5,061
Total Debt 46 90 88 54
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bright Minds Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bright Minds‘s full profile, request access.

Request a free trial

Bright Minds Patents

Bright Minds Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023264112-A1 Azepinoindoles and methods of preparation thereof Pending 06-May-2022
EP-4519266-A1 Azepinoindoles and methods of preparation thereof Pending 06-May-2022
EP-4519266-A4 Azepinoindoles and methods of preparation thereof Pending 06-May-2022
US-20250296934-A1 Azepinoindoles and methods of preparation thereof Pending 06-May-2022
WO-2023212811-A1 Azepinoindoles and methods of preparation thereof Inactive 06-May-2022 C07D487/04
To view Bright Minds’s complete patent history, request access »

Bright Minds Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bright Minds ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Bright Minds’s complete esg history, request access »

Bright Minds FAQs

  • When was Bright Minds founded?

    Bright Minds was founded in 2017.

  • Where is Bright Minds headquartered?

    Bright Minds is headquartered in New York, NY.

  • What is the size of Bright Minds?

    Bright Minds has 25 total employees.

  • What industry is Bright Minds in?

    Bright Minds’s primary industry is Drug Discovery.

  • Is Bright Minds a private or public company?

    Bright Minds is a Public company.

  • What is Bright Minds’s stock symbol?

    The ticker symbol for Bright Minds is DRUG.

  • What is the current stock price of Bright Minds?

    As of 13-Nov-2026 the stock price of Bright Minds is $22.96.

  • What is the current market cap of Bright Minds?

    The current market capitalization of Bright Minds is $226M.

  • What is Bright Minds’s annual earnings per share (EPS)?

    Bright Minds’s EPS for 12 months was -$2.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process